|
TOP STORIES
One Step Closer to an Artificial Nerve Cell
Scientists at Karolinska Institutet and Linköping University are well on the way to creating the first artificial nerve cell that can communicate specifically with nerve cells in the body using neurotransmitters. (Karolinska Institutet, Stockholm)
|
|
SCIENCE NEWS
New Study Shows Granulocyte-colony Stimulating Factor Impacts both Bone Marrow and Brain to Improve Cognition
A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease researchers have found. (USF Health, University of South Florida, Tampa)
New Findings Show Brain Plasticity May Also Be Essential for Stability
Researchers at the Hotchkiss Brain Institute, University of Calgary, have found that synaptic plasticity, long implicated as a device for 'change' in the brain, may also be essential for stability. (Hotchkiss Brain Institute, University of Calgary, Calgary)
CU-Boulder Study Finds Brain's Immune System May Cause Chronic Seizures
Chronic seizures caused by traumatic head injuries may result from chemicals released by the brain's immune system attempting to repair the injured site, according to a recent study. (University of Colorado-Boulder, Boulder)
Living Cell Technologies' Encapsulated Choroid Plexus Cells May Be Used To Treat Hearing Loss
Living Cell Technologies Limited recently reports that its encapsulated choroid plexus cells (NeurotrophinCell, NTCell) were shown to protect nerve cells in the inner ear from degeneration in studies done with the Bionic Ear Institute. (Living Cell Technologies Limited, Melbourne)
ReNeuron Announces Publication of Data on Mechanism of Action of Lead CTX Stem Cell Line
ReNeuron Group plc recently announced the publication in Stem Cells and Development 1 of pre-clinical data concerning the potential mechanism of action of ReNeuron's lead CTX neural stem cell line in stroke and neurodegenerative diseases.
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
|
|
INDUSTRY
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
Johnson and Johnson, and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Johnson and Johnson, and Elan Corporation plc recently announced a definitive agreement whereby Johnson and Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program, through a newly formed company.
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
iZumi Bio, Inc. and Pierian, Inc. recently announced they have merged to form a new company, iPierian, Inc. Building on the iZumi infrastructure and vision, the company is focused on the application of cellular reprogramming to change the paradigm of drug discovery.
GE Healthcare and Geron Announce Exclusive Global Agreement to Commercialize Stem Cell Drug Discovery Technologies
GE Healthcare and Geron Corporation recently announced that they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells for use in drug discovery, development and toxicity screening.
Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA
Fate Therapeutics said recently that it has acquired from the University of California, Los Angeles, exclusive intellectual property rights covering small molecule compositions and methods for inducing bone formation.
Pluristem Therapeutics Was Awarded a $1.9 Million Grant from the Office of the Chief Scientist in the Israeli Government
Pluristem Therapeutics Inc. announced recently that the company was awarded a $1.9 million government grant from the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of Israel.
First cGMP Feeder-independent Pluripotent Stem Cell Banks Released for Distribution
The WiCell Research Institute and the Waisman Clinical Biomanufacturing Facility announced recently the release of the first current Good Manufacturing Practices feeder-independent pluripotent stem cell banks available for sale and distribution to researchers worldwide.
Start-Ups Say Innovation Doesn't Grow on Trees
When nearly $10 billion in stimulus funds went to the NIH this year, a last-minute change in the legislation exempted the agency from setting aside 2.8 percent of its research budget for small businesses and the commercialization of technologies developed at universities.
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
